Advertisement
Australia markets close in 2 hours 19 minutes
  • ALL ORDS

    8,002.80
    -73.90 (-0.91%)
     
  • ASX 200

    7,731.20
    -73.30 (-0.94%)
     
  • AUD/USD

    0.6583
    +0.0001 (+0.01%)
     
  • OIL

    79.42
    +0.43 (+0.54%)
     
  • GOLD

    2,319.10
    -3.20 (-0.14%)
     
  • Bitcoin AUD

    93,626.06
    -1,958.53 (-2.05%)
     
  • CMC Crypto 200

    1,313.48
    +18.81 (+1.45%)
     
  • AUD/EUR

    0.6122
    +0.0005 (+0.08%)
     
  • AUD/NZD

    1.0958
    +0.0009 (+0.08%)
     
  • NZX 50

    11,709.04
    -73.85 (-0.63%)
     
  • NASDAQ

    18,085.01
    -6.43 (-0.04%)
     
  • FTSE

    8,354.05
    +40.38 (+0.49%)
     
  • Dow Jones

    39,056.39
    +172.13 (+0.44%)
     
  • DAX

    18,498.38
    +68.33 (+0.37%)
     
  • Hang Seng

    18,525.49
    +211.63 (+1.16%)
     
  • NIKKEI 225

    38,404.69
    +202.32 (+0.53%)
     

Estimating The Intrinsic Value Of Redox Limited (ASX:RDX)

Key Insights

  • Redox's estimated fair value is AU$2.41 based on Dividend Discount Model

  • Redox's AU$2.52 share price indicates it is trading at similar levels as its fair value estimate

  • Redox's peers seem to be trading at a higher premium to fair value based onthe industry average of -41%

How far off is Redox Limited (ASX:RDX) from its intrinsic value? Using the most recent financial data, we'll take a look at whether the stock is fairly priced by projecting its future cash flows and then discounting them to today's value. We will take advantage of the Discounted Cash Flow (DCF) model for this purpose. Before you think you won't be able to understand it, just read on! It's actually much less complex than you'd imagine.

Companies can be valued in a lot of ways, so we would point out that a DCF is not perfect for every situation. If you still have some burning questions about this type of valuation, take a look at the Simply Wall St analysis model.

ADVERTISEMENT

Check out our latest analysis for Redox

Is Redox Fairly Valued?

As Redox operates in the trade distributors sector, we need to calculate the intrinsic value slightly differently. In this approach dividends per share (DPS) are used, as free cash flow is difficult to estimate and often not reported by analysts. This often underestimates the value of a stock, but it can still be good as a comparison to competitors. We use the Gordon Growth Model, which assumes dividend will grow into perpetuity at a rate that can be sustained. The dividend is expected to grow at an annual growth rate equal to the 5-year average of the 10-year government bond yield of 2.2%. We then discount this figure to today's value at a cost of equity of 8.3%. Compared to the current share price of AU$2.5, the company appears around fair value at the time of writing. Remember though, that this is just an approximate valuation, and like any complex formula - garbage in, garbage out.

Value Per Share = Expected Dividend Per Share / (Discount Rate - Perpetual Growth Rate)

= AU$0.1 / (8.3% – 2.2%)

= AU$2.4

dcf
dcf

Important Assumptions

The calculation above is very dependent on two assumptions. The first is the discount rate and the other is the cash flows. Part of investing is coming up with your own evaluation of a company's future performance, so try the calculation yourself and check your own assumptions. The DCF also does not consider the possible cyclicality of an industry, or a company's future capital requirements, so it does not give a full picture of a company's potential performance. Given that we are looking at Redox as potential shareholders, the cost of equity is used as the discount rate, rather than the cost of capital (or weighted average cost of capital, WACC) which accounts for debt. In this calculation we've used 8.3%, which is based on a levered beta of 1.325. Beta is a measure of a stock's volatility, compared to the market as a whole. We get our beta from the industry average beta of globally comparable companies, with an imposed limit between 0.8 and 2.0, which is a reasonable range for a stable business.

SWOT Analysis for Redox

Strength

  • Debt is not viewed as a risk.

Weakness

  • Earnings declined over the past year.

  • Dividend is low compared to the top 25% of dividend payers in the Trade Distributors market.

Opportunity

  • Annual revenue is forecast to grow faster than the Australian market.

  • Good value based on P/E ratio compared to estimated Fair P/E ratio.

Threat

  • Dividends are not covered by earnings.

Looking Ahead:

Although the valuation of a company is important, it is only one of many factors that you need to assess for a company. It's not possible to obtain a foolproof valuation with a DCF model. Instead the best use for a DCF model is to test certain assumptions and theories to see if they would lead to the company being undervalued or overvalued. For example, changes in the company's cost of equity or the risk free rate can significantly impact the valuation. For Redox, there are three pertinent factors you should assess:

  1. Risks: For example, we've discovered 1 warning sign for Redox that you should be aware of before investing here.

  2. Future Earnings: How does RDX's growth rate compare to its peers and the wider market? Dig deeper into the analyst consensus number for the upcoming years by interacting with our free analyst growth expectation chart.

  3. Other Solid Businesses: Low debt, high returns on equity and good past performance are fundamental to a strong business. Why not explore our interactive list of stocks with solid business fundamentals to see if there are other companies you may not have considered!

PS. Simply Wall St updates its DCF calculation for every Australian stock every day, so if you want to find the intrinsic value of any other stock just search here.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.